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Abstract
Background: Metabolic engineering aims at channeling the metabolic fluxes towards a desired compound. An
important strategy to achieve this is the modification of the expression level of specific genes. Several methods for
the modification or the replacement of promoters have been proposed, but most of them involve time-consuming
screening steps. We describe here a novel optimized method for the insertion of constitutive promoters (referred
to as “promoter knock-in”) whose strength can be compared with the native promoter by applying a promoter
strength predictive (PSP) model.
Results: Our method was successfully applied to fine tune the ppc gene of Escherichia coli. While developing the
promoter knock-in methodology, we showed the importance of conserving the natural leader region containing
the ribosome binding site (RBS) of the gene of interest and of eliminating upstream regulatory elements
(transcription factor binding sites). The gene expression was down regulated instead of up regulated when the
natural RBS was not conserved and when the upstream regulatory elements were eliminated. Next, three different
promoter knock-ins were created for the ppc gene selecting three different artificial promoters. The measured
constitutive expression of the ppc gene in these knock-ins reflected the relative strength of the different promoters
as predicted by the PSP model. The applicability of our PSP model and promoter knock-in methodology was
further demonstrated by showing that the constitutivity and the relative levels of expression were independent of
the genetic background (comparing wild-type and mutant E. coli strains). No differences were observed during
scaling up from shake flask to bioreactor-scale, confirming that the obtained expression was independent of
environmental conditions.
Conclusion: We are proposing a novel methodology for obtaining appropriate levels of expression of genes of
interest, based on the prediction of the relative strength of selected synthetic promoters combined with an
optimized promoter knock-in strategy. The obtained expression levels are independent of the genetic background
and scale conditions. The method constitutes therefore a valuable addition to the genetic toolbox for the
metabolic engineering of E. coli.
Background
The ability to alter metabolic fluxes by modifying the
expression of the cognate genes is an important tool for
metabolic engineering. Metabolic engineering by gene
manipulation traditionally aimed at abolishing undesired
metabolic activities, introducing new enzymatic activities,
and/or generating many-fold overexpression of what was
believed to be a rate determining step in a pathway. In
some cases, these methods have been successful in redir-
ecting the flux to a certain product but more often, the
outcome has been disappointing because of the limited
impact of the manipulations on the targeted result. This
clearly illustrates the importance of obtaining a quantita-
tive understanding of the factors that determine the flux
through a pathway, e.g. by applying metabolic control
analysis to define the best strategy for flux optimization.
A comparatively straightforward approach to modify the
flux through a pathway consists in the modulation of cel-
lular enzymatic activities by changing the expression
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libraries have been constructed for this purpose [1-11].
Bacterial genes are differentially expressed during the
cell cycle in response to a wide variety of signals that mod-
ulate promoter activity and in some cases it may be inter-
esting, however, to express specific genes constitutively
and at a specific level. To ensure the constant (over)
expression of a certain gene, the endogenous promoter
can be replaced by a constitutive promoter with a desired
strength. In this context, a synthetic promoter library is
useful for the fine tuning of genes. To date, there are com-
paratively few data about the insertion procedure of artifi-
cial promoters directly in the chromosome [1,8]. The
existing methods contain elements of randomness, in the
sense that they create a collection of promoters for each
gene of interest that needs to be screened for the appropri-
ate expression. In a next step, the chromosomal promoter
can be replaced by an artificial one specifically constructed
for the targeted gene. Therefore, a more direct, less time-
consuming approach to modify promoter strength is desir-
able. The present method optimizes the insertion proce-
dure of promoters selected from a previously
characterized library. We describe an optimized procedure
for the fine tuning of gene expression, using as proof of
concept the ppc gene of Escherichia coli (coding for phos-
phoenolpyruvate carboxylase). The advantage of this pro-
cedure over the state-of-the art procedures is the universal
applicability of the created artificial promoter library in
combination with a promoter strength predictive (PSP)
model [3], making it unnecessary to create a new promo-
ter library for each targeted gene. Hence, the proposed
strategy is less time consuming and cheaper.
First, we compare several knock-in strategies of
upstream untranslated regions containing a synthetic pro-
moter with or without a synthetic canonic ribosome bind-
ing site (RBS) and with or without an N-terminal
polyhistidine sequence (His-tag). Second, we apply the
optimized procedure to knock-in synthetic promoters
with different strength, selected using a previously devel-
oped promoter strength predictive (PSP) model. At the
same time, this work constitutes a validation of the PSP
model [3]. Third, we investigate the possible influence of
the genetic background and scale up conditions on the
expression. This is important to exclude the possibility
that the expression of our proof of concept, ppc,i sc o n -
trolled by a regulator which can bind on an unknown
transcription factor binding site located within the used
artificial promoters or the flanking regions in the genome.
Results
Selection of synthetic promoters for the optimization of
the knock-in procedure, using the PSP model
The PSP model was developed to quantitatively predict
the strength of promoters on the basis of the nucleotide
sequence [3]. A relative strength of 0.20 was calculated
with this model for the endogenous promoter of the ppc
gene (ppcp) in a scale from 0 to 1.00 defined by a library
of 42 synthetic promoters. Out of the library, two stron-
ger synthetic promoters, p37 (0.82) and p55 (0.36), were
chosen for the knock-in experiments.
Knock-in strategies to insert promoters
The ppcp was chosen to be rationally replaced.
Upstream of the ppc gene, there is a 91 nt leader region
harboring two RBS sequences, a promoter region with
-10 and -35 boxes [12], and three repeated sequences
(from -62 to -506) (figure 1). The relevance to ppc
expression of the repeated sequences is not known.
In a first attempt, a cassette containing the antibiotic
resistance marker, the synthetic p37 promoter, a canoni-
cal RBS, a start codon and a polyhistidine sequence (tag)
substituted the start codon of the ppc gene (figure 2a).
The obtained mutant was grown in triplicate at flask
scale to compare gene expression at transcriptomic and
enzymatic level to the wild-type (wt), (table 1). The inser-
tion of the artificial promoter resulted in a 2-fold reduc-
tion of expression of the ppc gene. Therefore, a second
strategy was designed to replace the sequence from posi-
tion -506 nt to the start codon (+94) by the p37 promoter
with an artificial RBS and a start codon followed by a
polyhistidine sequence (figure 2b) to eliminate the influ-
ence of a putative transcription factor binding site [13]
which is located upstream of the endogenous promoter
on the artificial promoter. Interestingly, an even stronger
reduction in the mRNA level (5- to 6-fold) compared to
the wt was observed (table 1). To exclude that the
observed reduction of expression was due to the presence
of the polyhistidine sequence, the latter approach was
repeated by inserting the p37 promoter with its RBS but
without the polyhistidine sequence (not shown in the dia-
gram). However, a similar reduction of expression was
observed (0.3 (0.2-0.4)). A possible explanation is that the
synthetic leader region was not adequate to ensure
mRNA stability [14]. Consequently, a third strategy was
designed, respecting the natural RBS region, with intro-
ducing neither the polyhistidine sequence nor the syn-
thetic RBS. The cassette with the p37 promoter replaced
the sequence from -506 to -1 (figure 2c). This approach
resulted in a successful 3- to 4-fold increase in expression
of the ppc gene (3.9 compared to 1.0). A similar increase
was observed at the enzymatic level (3.33 versus 1.00)
(table 1). These results are in agreement with what was
predicted by the PSP model.
Verification of the promoter knock-in procedure and of
the PSP model
Two synthetic promoters (p37 and p55) were chosen on
the basis of their relative strength to replace the natural
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procedure with the p37 promoter, the same approach
was followed with the p55 promoter. The expression of
the ppc gene in the wt and the mutant was measured as
before. A 2.5-fold increase of ppc expression was
observed (table 2). As shown in figure 3, there is a good
correlation between the relative expression from the
synthetic promoters at both transcriptomic and enzy-
matic activity levels and the predicted promoter
strengths using the PSP model.
Next, the influence of the genetic background on the
expression of ppc from the synthetic promoter was
investigated. The p37 and p55 promoters were knocked-
in in an E. coli MG1655 mutant in which three genes
coding for enzymes involved in the pyruvate oxidation
pathway were knocked-out. The expression of the ppc
gene in the mutant strains was measured relative to the
wt strain at transcriptomic and enzymatic activity level
(table 2). The expression of the ppc gene in the 3KO
strain seems to be down regulated compared to the wt
strain (0.7 versus 1.0) despite the fact that no regulatory
elements have yet been identified in the ppc operon.
According to Lesnik and coworkers (2005) [13], this
m a yb ed u et oap u t a t i v et r a n s c r i p t i o nf a c t o rb i n d i n g
site that is located upstream of the ppc promoter. These
results seem to indicate that the introduction of
Figure 1 The natural ppc promoter. RBS: Ribosome Binding Site; RS: Repetitive sequences indicated by arrows; putative transcription factor
binding site is underlined with a discontinuous line.
Figure 2 Strategies to replace the natural ppc promoter by an artificial promoter. (a) Strategy I: insertion of a promoter + artificial RBS and
a polyHis-tag sequence between the ppc gene and its natural promoter (b) Strategy II: replacement of natural promoter by a promoter +
artificial RBS and a polyHis-tag sequence (c) Strategy III: replacement of natural promoter by artificial promoter, keeping the natural RBS.
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Page 3 of 9Table 1 Expression of the ppc gene with the artificial p37 promoter inserted with the 3 different strategies at
transcriptomic level (qPCR) and enzyme expression level.
Strategy I Strategy II Strategy III
mRNA
(2
-ΔΔct)
PEP carboxylase
activity
mRNA
(2
-ΔΔct)
PEP carboxylase
activity
mRNA
(2
-ΔΔct)
PEP carboxylase
activity
Wild-type 1.0
(0.8-1.3)
1.00 ± 0.002 1.0
(0.7-1.5)
1.00 ± 0.002 1.0
(0.9-1.2)
1.00 ± 0.002
mutant 0.4
(0.3-0.5)
0.50 ± 0.003 0.2
(0.1-0.3)
0.13 ± 0.001 3.9
(3.3-4.5)
3.32 ± 0.015
Table 2 Expression of ppc gene with the artificial promoters relative to the natural promoter in strain MG1655 (wt)
and MG1655 ΔackA-pta, ΔpoxB (3KO).
Strain Flask-scale Bioreactor-scale
Expression of ppc relative to WT Expression of ppc relative to WT
mRNA (2
-ΔΔct) PEP carboxylase activity mRNA (2
-ΔΔct) PEP carboxylase activity
wt 1.0
(0.9-1.1)
1.00 ± 0.002 1.0
(0.9-1.1)
1.00 ± 0.002
3KO 0.7
(0.5-0.9)
0.82 ± 0.003 0.8
(0.7-0.9)
0.92 ± 0.005
wt - p37 3.9
(3.3-4.5)
3.33 ± 0.015 6.7
(5.8-7.8)
5.24 ± 0.013
wt - p55 2.5
(2.1-3.0)
1.79 ± 0.002 5.0
(4.7-5.2)
3.22 ± 0.014
3KO - p37 3.7
(3.3-4.3)
3.56 ± 0.002 5.7
(5.3-6.2)
4.71 ± 0.019
3KO - p55 2.3
(2.0-2.7)
2.02 ± 0.016 4.2
(3.9-4.5)
2.55 ± 0.007
Figure 3 Relation between the relative promoter strength of the natural ppc promoter and two artificial promoters (p55 and p37)
predicted using the PSP-model and measured using qPCR.
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the pyruvate oxidizing pathway) may create a novel phe-
notype of which the ppc expression is down regulated
compared to the wt. Hence, this new phenotype prob-
ably influences a regulator which binds to this putative
transcription factor binding site. Furthermore, these
results confirm that the relative strength of both p37
(3.9 and 3.7) and p55 (2.5 and 2.3) promoters was main-
tained in both the wt and the 3KO strains, respectively.
Moreover, the results at enzymatic level had the same
tendency (3.3 - 3.6 for promoter p37 and 1.8 - 2.0 for
promoter p55 in the wt - 3KO strains).
Next, the influence of growth parameters (oxygen sup-
ply, pH and culture volume (scaling up)) on the strength
of the knocked-in synthetic promoters in both the wt
and the 3KO strains was investigated using a bioreactor.
Again, a similar relative expression of the ppc gene was
observed at both transcriptomic and enzymatic activity
levels, showing that scaling up the culture conditions
affect the strength of the synthetic promoters keeping
the same tendency (6.7 - 5.7 for promoter p37 and 5.0 -
4.2 for promoter p55 in the wt - 3KO strains) (table 2).
Discussion
Several methods have been developed to engineer the
cellular metabolism by modifying the expression level of
genes coding for enzymatic steps that are considered
either rate-limiting or diverting the metabolic flow
towards by-products. One such approach is to modify
the promoter of genes using a promoter library. The
existing methods [8,15] generally yield a collection of
mutants which needs to be screened to select the
mutant with the desired expression level since the
expression cannot be predicted in advance. Hence, in a
recent review, Santos and Stephanopoulos (2008) [16]
stressed the need for a rational approach for the applica-
tion of existing promoter libraries. In the present work,
we developed a method based on the use of a previously
constructed library of promoters [3] in combination
with a mathematical model (Promoter Strength Predic-
tive, PSP) which can be applied for the fine tuning of
gene expression, using the ppc gene (phosphoenolpyru-
vate carboxylase) as model system. Three methodologi-
cal aspects were considered: (i) the optimization of the
knock-in procedure; (ii) the capability of the PSP model
to compare the strength of specific promoters in a col-
lection with a native promoter; (iii) the stability of the
engineered expression level when genetic background
(additional mutations) and growth conditions (scaling
up) are changed.
So far, little information is available about an efficient
method for the insertion of artificial promoters at the
chromosomal level. The multiple mutants obtained using
existing libraries require extensive screening steps. Alper
and co-workers (2005) [15] used their characterized
library of promoters to modulate the expression at chro-
mosomal level for fine tuning the expression of both
phosphoenolpyruvate carboxylase and deoxy-xylulose-P.
The strength of the artificial promoters was assayed with
indirect methods (biomass yield and lycopene produc-
tion, respectively). They concluded that the optimal gene
expression levels are variable and dependent on the
genetic background of the strain to achieve a specific
phenotype. However, they did not collect any transcrip-
t o m i cn o rp r o t e o m i cd a t a .W ea r ep r o p o s i n gan e w
method that allows to evaluate the strength of the
inserted promoter compared to the endogenous promo-
ter in advance. In addition, the obtained expression is
independent of additional genetic modifications and scal-
ing up conditions.
(i) Optimization of the knock-in procedure. In order
to maintain the expression of the chosen promoter it is
imperative to conserve the leader region (from tran-
scriptional to translational starting point) of the gene of
interest and to eliminate upstream regulatory elements
(transcription factor binding sites) (Strategy III). Simply
inserting a synthetic promoter between the coding
region and the natural promoter region (strategy I in
figure 2) or substituting the endogenous promoter
region by the same synthetic promoter fragment (Strat-
egy II in figure 2) results in a drastic decrease in expres-
sion (2- to 3-fold and 5- to 6-fold, respectively). An
N-terminal polyhistidine coding sequence, to allow an
eventual quick purification of the protein of interest,
was present in the two constructs. However, omitting
this sequence in another construct did not improve
expression. Substituting the natural promoter region
506 nt upstream of the transcription start while retain-
ing the ppc gene 5’ untranslated region (leader region)
resulted in a 3-fold increase of expression, at both tran-
scriptomic and enzymatic activity levels (table 1). Thus,
a level of transcription corresponding to that predicted
by the PSP model was obtained and, importantly, the
increase in mRNA levels was translated into an increase
in protein activity. Incidentally, this indicates that there
is no post-translational regulation of the ppc gene. It is
known that the untranslated sequence at the 5’ end of
mRNA, beyond its role in engaging ribosomes, is impor-
tant for the stability of the transcript. Changes in this
sequence may therefore affect the expression of the
downstream gene, which seems to have been the case
here with constructions I and II. This was also observed
by Solem and Jensen in their gene expression modula-
tion experiments [17]. It should be noted that in order
to knock-in the artificial promoters successfully in front
of the ppc gene, the repetitive sequences upstream of
the endogenous promoter had to be eliminated as well.
Hence, the putative transcription factor binding site
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(2005) [13] was removed. As the purpose here is to
obtain the stable constitutive expression of a cellular
activity, the elimination of this (putative) regulatory site
is desirable.
(ii) The expression levels obtained with the two syn-
thetic promoters from our library (p37 and p55) confirm
the use of the PSP model to choose promoters in func-
tion of the desired level of expression. Indeed, the
expression levels relative to wild-type were in quite
good agreement with the predicted relative strengths.
(iii) The engineered ppc expression was independent
of the genetic background, insofar as the introduction of
additional mutations affecting connected metabolic
branches did not affect the expression from the two
promoters. The relative strength of expression remained
the same in a strain in which three genes (the ackA,
pta,a n dpoxB genes involved in the pyruvate oxidation
pathway) were knocked out. Changing the growth con-
ditions by scaling up from shake-flasks to 1.5 L bioreac-
tor conditions did not affect expression either.
Furthermore, our promoter knock-in procedure ensures
constitutive expression.
In conclusion, a rational approach for the modulation
of gene expression, using a library of promoters in com-
bination with a mathematical model, is proposed. The
developed promoter knock-in method ensures the stable
expression of the targeted gene. In addition, the knock-
in procedure is almost “seamless”, leaving only an 84 nt
insert with no selection markers such as antibiotic resis-
tance genes in the genome. Therefore, the method does
not impose limitations on the further introduction of
other synthetic promoters for the fine tuning of several
other genes expression in the same E. coli strain.
We also applied this method to create a selection host
for the detection of L-ribose isomerase expressing
mutants of Escherichia coli [18] and to fine tune the
expression of the membrane transport protein dcuC
[19]. This indicates that the proposed procedure is also
applicable for other genes.
Conclusion
State of the art methods for the utilization of existing
promoter libraries prove to be suboptimal for the fine
tuning of gene expression and therefore there is a need
for a rational promoter knock-in method. In this study,
we demonstrated the usefulness of an existing promoter
strength predictive model (PSP) to compare in advance
the relative strength of the promoters in the library with
the native promoter so that the latter can be replaced
with an appropriate one of the former. Further, we
developed an optimal strategy to knock-in promoters.
Existing methods are time consuming and expensive
since they involve post-insertion screening steps. We
present a novel method in which the strength of the
inserted promoter relative to the natural one is known
beforehand and in which the obtained expression is
independent of genetic background. The method is
therefore a valuable addition to the E. coli metabolic
engineering toolbox.
Methods
Bacterial strains and plasmids
The wild-type (wt) strain Escherichia coli MG1655 [l
-,F
-,
rph-1, rfb-50, ilvG
-, fnr
-]w a so b t a i n e df r o mt h eN e t h e r -
lands Culture Collection of Bacteria (NCCB, Utrecht,
The Netherlands). The mutant strain E. coli MG1655
ΔackA-pta, ΔpoxB [l
-,F
-, rph-1, rfb-50, ilvG
-, fnr
-,
ΔackA-pta, ΔpoxB] was constructed using the method of
Datsenko & Wanner (2000) [20] and it is referred to as
3KO. The plasmids pKD46 (Red helper plasmid, Ampicil-
lin resistance), pKD3 (containing an FRT-flanked chlor-
amphenicol resistance (cat) gene), pKD4 (containing an
FRT-flanked kanamycin resistance (kan) gene), and
pCP20 (expressing FLP recombinase activity) were
obtained from Prof. Dr. J-P Hernalsteens (Vrije Universi-
teit Brussel, Belgium). The artificial promoter library was
constructed by De Mey et al. (2007) [3]. The plasmid
pBluescript (Fermentas, St. Leon-Rot, Germany) was
used to create the promoter delivery constructs.
Culture conditions
The culture medium Luria Broth (LB) consisted of 1%
tryptone-peptone (Difco, Erembodegem, Belgium), 0.5%
yeast extract (Difco) and 0.5% sodium chloride (VWR,
Leuven, Belgium). The pH of the medium was 6.7.
For flask cultures, minimal medium (MM-flask) con-
sisted of 18 μMF e C l 2.4H2O (Merck, Leuven, Belgium),
34 μMC a C l 2.2H2O( M e r c k ) ,8 . 3μMM n C l 2.2H2O
(Merck), 2.2 μM CuCl2.2H2O (Sigma, Bornem, Belgium),
2,1 μMC o C l 2.6H2O( M e r c k ) ,6 . 9μMZ n C l 2 (Merck),
0.4 μMH 3BO4 (Merck), 40.3 μMN a 2EDTA.2H2O
(Fluka, Bornem, Belgium), 3 μM thiamine HCl (Sigma),
0.4 μMN a 2MoO4.2H2O( F l u k a ) ,3 7 . 4m MN H 4Cl
(Merck), 37.8 mM (NH4)2SO4 (Merck), 22 mM KH2PO4
(Acros, Geel, Belgium), 42 mM K2HPO4 (Acros),
40 mM MOPS (Sigma), 2 mM MgSO4.7H2O( F l u k a ) ,
8.6 mM NaCl (VWR) and 83.3 mM glucose.H2O( S t o p ,
Dendermonde, Belgium). The pH was set at 7.0 with a
1MK 2HPO4 (Acros) solution.
For batch cultures, the minimal medium (MM-batch)
composition was identical to MM-flask, except for the
concentration of KH2PO4 14.7 mM, and the absence of
MOPS. The pH was not set to 7.0, but left at approx 5.4.
A preculture from a single colony was grown in 5 ml
MM-flask medium overnight and 2 ml was transferred
to 100 ml MM-flask medium in a 0.5 l flask. Incubation
was performed at 37°C in a rotary shaker (160 rpm) for
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ml was used to inoculate 1.5 l MM-batch in a Biostat M
fermentor (Sartorius Stedim Biotech S.A., Melsungen,
Germany). In batch cultures, the pH (7.0) was kept con-
stant using 4 N KOH and 1 N H2SO4, the temperature,
agitation and air supply were set at 37°C, 1000 rpm, and
1.5 l/min, respectively. The pH, pO2, temperature, agita-
tion, used acid and used base were followed online
using the MFCS/WIN software of Sartorius Stedim Bio-
tech S.A. Samples were taken using a rapid sampling
loop. Each hour, a sample for OD600 and extracellular
measurements was taken using the stainless bead sam-
pling method as described by Mashego et al. [21], fol-
lowed by cold centrifugation. During exponential
growth, a sample was taken every 30 min. At OD600 =
1, 1 ml samples were taken for total RNA extraction
and enzymatic activity measurements.
Promoter delivery plasmids
Two selected promoters (p37, and p55) (table 3) were
amplified from an existing promoter library [3] by PCR
with primers (Fw-EcoRI-p37/Rv-BamHI-p37, and Fw-
EcoRI-p55/Rv-BamHI-p55, respectively) flanked with
restriction site regions (EcoRI and BamHI) (table 3). The
antibiotic resistance genes (for chloramphenicol or kana-
mycin resistance) flanked with FRT sites were amplified
by PCR with primers (Fw-EcoRI-P1/Rv-HindIII-P2) car-
rying the restriction site regions (EcoRI and HindIII) and
priming sites from pKD3 and pKD4, respectively. The
PCR products were digested with the appropriate restric-
tion enzymes and introduced in a vector (p-Bluescript)
previously linearised (BamHI and HindIII). After verifica-
tion of the promoter sequence, the final plasmid was
used as template in the promoter knock-in procedure.
Promoter knock-in procedure
The promoter knock-in system is based on the l Red-
mediated one step recombination procedure for creating
a knock-out mutant as described by Datsenko and Wan-
ner [20], with several modifications. The basic strategy is
to replace a chromosomal sequence with a cassette con-
taining a selectable antibiotic resistance gene and the
sequence to be inserted. The cassette is generated by
PCR by using primers with circa 50 nt homology exten-
sion (H1 and H2).
Strategies for the insertion of an artificial promoter
The design of the primers (table 3) for the replacement
of the endogenous ppc promoter (ppcp) was based on
different strategies: (i) insertion of an artificial promoter,
plus an artificial ribosomal binding site (RBS) and a
polyHis-tag sequence between the ppc gene and the
ppcp (Fw-ppc-HIS-RBS-37(55)/Rv-ppc-P2); (ii) replace-
ment of ppcp by an artificial promoter, an artificial RBS
and a polyHis-tag sequence (Fw-ppc-HIS-RBS-37(55)/
Rv-ppc-3-P2); (iii) replacement of ppcp by an artificial
promoter, but respecting the transcriptional starting
point and the natural RBS (Fw-ppc-37(55)/Rv-ppc-3-P2).
In strategies I and II, a polyHis-tag was included to
facilitate detection and purification of the protein.
Quantitative PCR
The wild-type and the mutants were grown in flasks in
20 ml MM-flask medium in triplicate. One ml samples
were collected at OD600 =1 . 0f o rm R N Aa n dp r o t e i n
collection. Total RNA extraction was done using the
RNeasy mini kit of Qiagen® (KJ Venlo, The Nether-
lands). The purity of RNA was verified on a FA-agarose
gel as recommended by Qiagen® and the RNA concen-
tration was determined by measuring the absorbance at
260 nm. 2 μg RNA was used to synthesize cDNA using
a random primer and RevertAid H Minus M-MulV
reverse trancriptase (Fermentas).
The strength of the promoter was determined by RT-
qPCR carried out in an iCycler IQ® (Bio-Rad, Eke, Bel-
gium) using the primers Fw-ppc-qPCR and Rv-ppc-qPCR.
Table 3 Sequences of used promoters and primers
Primer Sequence
Fw-EcoRI-p37 gggggaattccttacatgaaaaaggttcttg
Rv-BamHI-p37 ttttggatcccatctttgtttcctccgagaaaaatgacatataccacatgg
Fw-EcoRI-p55 gggggaattccttagaaggaatttgttcttg
Rv-BamHI-p55 ttttggatcccatctttgtttcctccgagatacctaaaaattatacc
Fw-EcoRI-P1 ttttgaattcgtgtaggctggagctgcttc
Rv-HindIII-P2 ggggaagcttcatatgaatatcctccttag
Fw-ppc-HIS-RBS-37 acattactacgcaatgcggaatattgttcgttgtggtgatggtgatggtgcgccatctttgtttcctccgagaaaaatgac
Fw-ppc-HIS-RBS-55 acattactacgcaatgcggaatattgttcgttgtggtgatggtgatggtgcgccatctttgtttcctccgagatacctaa
Rv-ppc-P2 cgtgaaggatacagggctatcaaacgataagatggggtgtctggggtaatcatatgaatatcctccttag
Rv-ppc-3-P2 atcaagcccacccgcgaactgataacccaggtaattcaccatttttgctggcattaacatatgaatatcctccttag
Fw-ppc-37 tccttcacgtcgcattggcgcgaatatgctcgggctttgcttttcgtcgtcaaaaatgacatataccacatgga
Fw-ppc-55 tttgccgagcatactgacattactacgcaatgcggaatattgttcgttcatctttgtttcctccgagatacctaaaaattataccacatcaac
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Page 7 of 9SYBR GreenER qPCR supermix (Invitrogen®) was used to
perform a brief UDG (uracil DNA glycolsylase) incubation
(50°C for 2 min) immediately followed by PCR amplifica-
tion (95°C for 8.5 min; 40 cycles of 95°C for 15 s and 60°C
for 1 min) and melting curve analysis (95°C for 1 min,
55°C for 1 min and 80 cycles of 55°C+0.5°C/cycles for
10 s) to identify the presence of primer dimers and analyze
the specificity of the reaction. This UDG incubation step
before PCR cycling destroys any contaminating dU-con-
taining products from previous reactions. UDG is then
inactivated by the high temperatures during normal PCR
cycling, thereby allowing the amplification of genuine tar-
get sequences. Each sample was performed in triplicate.
The relative expression ratios were calculated using the
“Delta-delta ct method” of PE Applied Biosystems (Perkin
Elmer, Forster City, CA). The gene rpoB was used as
housekeeping gene using the primers Fw-rpoB-qPCR and
Rv-rpoB-qPCR.
Phosphoenolpyruvate carboxylase assay
Cell lysis was performed with the EasyLyse™-kit (Epicen-
tre® Biotechnologies, BIOzymTC, Landgraaf, Nether-
lands), following the procedure recommended by the
supplier. PEP carboxylase activity was assayed as
described by De Maeseneire et al. [22]. The absorbance
at 415 nm was measured in a microplate reader (680
XR microplate reader, Bio-Rad, Eke, Belgium). PEP car-
boxylase activity was measured in the knock-in mutants
and in the wild-type.
List of abbreviations used
3KO: E. coli MG1655 ΔackA-pta, ΔpoxB;F R T :F L P
recognition target; KI: knock-in; KO: knock-out; PEP:
phosphoenolpyruvate; PLS: partial least square; ppcp:
promoter of the ppc gene; PSP model: promoter
strength predictive model; RBS: ribosome binding site;
RS: Repetitive Sequence; wt: wild-type.
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